Related Experiment Video
Updated: Jul 27, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
New approaches in the management of patients with chronic congestive heart failure
1Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Insights
Managing congestive heart failure (CHF) is costly. Evidence-based guidelines and newer therapies, including medical and surgical options, can improve patient outcomes and reduce healthcare expenses.
Area of Science:
- Cardiology
- Health Economics
Background:
- Congestive heart failure (CHF) presents a significant and escalating economic challenge.
- Existing evidence-based guidelines offer potential for cost savings and improved survival.
- Emerging research clarifies the roles of novel therapies in disease management.
Purpose of the Study:
- To review current evidence-based guidelines for managing congestive heart failure.
- To explore the potential of existing and novel medical and surgical therapies.
- To address the economic burden associated with heart failure care.
Main Methods:
- Review of current medical and surgical treatment strategies for CHF.
- Analysis of evidence-based guidelines for heart failure management.
- Discussion of the economic implications of various therapeutic approaches.
Main Results:
- Standard therapies (diuretics, ACE inhibitors, beta-blockers) improve symptoms, reduce hospitalizations, and enhance survival.
- Angiotensin receptor antagonists and cytokine antagonists are under investigation for their roles.
- Left ventricular assist device implantation shows potential for myocardial recovery and innovative surgical interventions.
Conclusions:
- Implementing evidence-based guidelines can mitigate the economic burden of CHF.
- Future strategies should integrate new knowledge while optimizing cost-effectiveness of treatments.
- A judicious approach to drug selection is crucial to avoid unnecessary costs at all disease stages.
Abstract:
The cost of caring for a growing number of patients with congestive heart failure is a staggering economic burden. Fortunately, an increasing number of evidence-based guidelines have been developed which, if implemented, have the potential to save lives and money. In addition, there are newer understandings about the potential of current therapies, both medical and surgical, to prevent the progression of disease. The foundation of diuretics, ACE inhibitors and beta-blockers serves to improve symptoms, decrease hospitalizations and improve survival. The roles of angiotensin receptor antagonists and cytokine antagonists are currently being clarified. The potential for myocardial recovery during left ventricular assist implantation has paved the way for some exciting surgical procedures. The challenge in the future will be to develop an approach to the patient with heart failure which takes advantage of this new knowledge while avoiding a bewildering array of costly drugs which may not all be necessary at all stages of the disease.
More Related Videos
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Heart Failure VII: Nursing Interventions
Cardiomyopathy V: Interprofessional Care

